Partner news
News
Partner news
Vect-Horus Announces Agreement With Johnson & Johnson Innovation
Read full storyPartner news
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Read full storyPartner news
Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders
Read full storyPartner news
Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen
Read full storyPartner news
Carrot Inc. Raises $25 Million to Commercialize Pivot, the Company's Digital Health Solution for Smoking Cessation
Read full storyPartner news
Touchlight announces collaboration with Janssen Biotech
Read full storyPartner news
CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases
Read full storyPartner news
Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
Read full storyPartner news
BIO-Europe® Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG
Read full storyPartner news
Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding
Read full storyPartner news
Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies
Read full storyPartner news
Provention Bio Announces Closing of Upsized Initial Public Offering
Read full storyPartner news
Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA
Read full storyPartner news